Prognostic Value of ¹⁸F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel

Table 1

Demographic and clinical characteristics of patients with CRPC at baseline ().

	Median (range) or no.	%
Age	71 (42–82)
ECOG
0	18	62
1	9	31
2	2	7
Gleason score
6-7	10	34
8-9	17	59
10	2	7
Baseline PSA
Median (range) (ng/ML)	54.4 (0.93–361)
Type of metastatic sites
Lung	2
Liver	3
Only bone	24
Only lymph nodes	23
Bone and lymph nodes	8
Local	5
No. of previous treatment for CRPC disease
None	5	17
One	21	73
Two or more	3	10